Stay updated with breaking news from B More Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- B.More Inc., a 501(c)(3) non-profit, clinical-stage biopharmaceutical company focused on the development of psychedelic medicines for substance...
/PRNewswire/ -- Two doses of psilocybin, a compound found in psychedelic mushrooms, reduces heavy drinking by 83% on average among heavy drinkers when combined...
WEDNESDAY, Aug. 24, 2022 (HealthDay News) -- Jon Kostas, a lifelong resident of New York City, started bar-hopping at age 13. At the height of his alcoholism, he was consuming
This randomized clinical trial evaluates the combination of psychotherapy with psilocybin vs active placebo in patients with alcohol use disorder.